CL King Starts PetMed Express (PETS) at Strong Buy
More News related to PETS
- Rosetta Stone Inc.'s Tom Adams Named Ernst & Young Entrepreneur of the Year(R) 2009 Overall National Winner
- PetMed Express D/B/A 1-800-PetMeds Announces Its Quarterly Dividend
- Wedbush Maintains a 'Neutral' on PetMed Express (PETS); Lowers Price Target
- Unusual 11 Mid-Day Movers 10/19: FIGI, IPCS, BEST, AMPL Higher; FNM, FRE, IDCC, PETS Lower
- PetMed (PETS) Shares Trade Lower This Morning on Lower Revenue
More News related to New Coverage
- Highlights From Take-Two Interactive Softwares' (TTWO) Forecast Teleconference
- Saks (SKS) Restates Q3 EPS to $0.04, Up from $0.01
- Big Lots (BIG) Delivers With Strong Q3 Results and Guidance
- Royal Bank Of Canada (RY) Posts Q4 EPS of CDN $1.06, Tops by 1c
- Sirona Dental (SIRO) Swings to Q4 Profit
CL King initiates coverage on PetMed Express (Nasdaq: PETS) with a Strong Buy rating.
PetMed Express, Inc., doing business as 1-800-PetMeds, engages in the marketing and sale of prescription and non-prescription pet medications, and other health products for dogs, cats, and horses.
Related Categories
New CoverageStocks Mentioned
+0.20Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
